Use of Baclofen for Alcohol Use Disorders in the United States

por Garbutt, James C.
Publicado 2018

Risk and resilience for alcohol use disorder revealed in brain functional connectivity

por Elton, Amanda, Garbutt, James C., Boettiger, Charlotte A.
Publicado 2021

Is glycaemic control associated with dietary patterns independent of weight change in people newly diagnosed with type 2 diabetes? Prospective analysis of the Early-ACTivity-In-Dia...

por Garbutt, James, England, C., Jones, A. G., Andrews, R. C., Salway, R., Johnson, L.
Publicado 2022

Efficacy and tolerability of baclofen in a U.S. community population with alcohol use disorder: a dose-response, randomized, controlled trial

por Garbutt, James C., Kampov-Polevoy, Alexei B., Pedersen, Cort, Stansbury, Melissa, Jordan, Robyn, Willing, Laura, Gallop, Robert J.
Publicado 2021

The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective

por de Beaurepaire, Renaud, Sinclair, Julia M. A., Heydtmann, Mathis, Addolorato, Giovanni, Aubin, Henri-Jean, Beraha, Esther M., Caputo, Fabio, Chick, Jonathan D., de La Selle, Patrick, Franchitto, Nicolas, Garbutt, James C., Haber, Paul S., Jaury, Philippe, Lingford-Hughes, Anne R., Morley, Kirsten C., Müller, Christian A., Owens, Lynn, Pastor, Adam, Paterson, Louise M., Pélissier, Fanny, Rolland, Benjamin, Stafford, Amanda, Thompson, Andrew, van den Brink, Wim, Leggio, Lorenzo, Agabio, Roberta
Publicado 2019